At the end of 2017, with the demand for the use of biologics in orthopedics outstripping the science as well as the safety and efficacy information available, leaders of the Arthroscopy Association of North American, the American Orthopaedic Society for Sports Medicine and the International Cartilage Regeneration and Joint Preservation Society formed the Biologic Association to provide high-level evidence to physicians and patients and to advance this treatment.

“We felt it was important for us to get into the biologics space and to establish some criteria for research, analysis, establishing registries and for promulgating this information through scholarly activities and meetings,” Louis F. McIntyre, MD, Chief Quality Officer for U.S. Orthopedic Partners, told Healio Orthopedics.

Click HERE to read full article.